Hektas Ticaret T.A.S.
HEKTS.IS
Below: live stock price for Hektas Ticaret T.A.S. (HEKTS.IS), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.
- Prev close
- $0.12
- Volume
- $20.23M
- Market cap
- $1.06B
- Currency
- USD (native TRY)
Financials
- 52w high
- ₺5.27
- 52w low
- ₺2.76
- 52w change
- 40.26%
- Day high
- ₺4.58
- Day low
- ₺4.28
- PEG
- 0.85
- Price / Book
- 246.11
- Beta (5Y)
- -0.31
- Enterprise value
- 48.42B
- EV / Revenue
- 8.62
- EV / EBITDA
- -26.35
- EPS (TTM)
- -₺0.42
- Payout ratio
- 0.00%
- Revenue (TTM)
- 5.62B
- EBITDA
- -1.84B
- Free cash flow
- -298.56M
- Total cash
- 1.98B
- Total debt
- 12B
- Debt / Equity
- 75.09
- Current ratio
- 0.58
- Quick ratio
- 0.32
- Profit margin
- -63.18%
- Gross margin
- -2.98%
- Return on assets
- -6.11%
- Return on equity
- -23.47%
- Shares outstanding
- 8.43B
- Float
- 3.76B
Hektas Ticaret T.A.S. manufactures, imports, and markets agricultural products, fertilizers and veterinary medicines in Turkey. The company's crop protection products include fungicides, herbicides, insecticides, acaricides, fumigants and nemathists, harvesting aids and plant growth regulators, winter struggle medicines and summer oils, spreads-adhesives, biological products, and feromons. It also offers smart base, leaf, pure, and fertilizers; organominerals; drip irrigation; biological preparation; and other plant nutrition products. In addition, the company provides ruminant, poultry, and pet products, as well as environmental health and seeds products. Hektas Ticaret T.A.S. was incorporated in 1956 and is headquartered in Gebze, Turkey.
Analyst & Risk
- Beta (vs S&P 500)
- -0.31
- very stable
- 52-week change
- 40.26%
- Debt / Equity
- 75.09
- very high leverage
- Current ratio
- 0.58
- Quick ratio
- 0.32
- ROE
- -23.47%
- ROA
- -6.11%
- PEG ratio
- 0.85
- potentially undervalued
- EV / Revenue
- 8.62
- EV / EBITDA
- -26.35
- Revenue growth
- -18.70%
- EBITDA
- -1.84B
- Free cash flow
- -298.56M
- Total cash
- 1.98B
- Total debt
- 12B
- Insider holdings
- 55.37%
- Institutional
- 3.81%
Recent news
- Altimmune Touts Pemvidutide Momentum Ahead of Phase 3 MASH TrialMarketBeat4m ago
- Uber reveals an unexpected problem behind the AI boomTheStreet6m ago
- Dow Jones Futures: Techs Fall After Dow Hits High, AI Shrugs Off Broadcom, Ciena; Jobs Report LoomsInvestor's Business Daily6m ago
- NMAA board approves 'one free transfer' rule; schools get final sayAlbuquerque Journal, N.M.8m ago
- New Mexico's AG files suit against sports betting firm KalshiAlbuquerque Journal, N.M.10m ago
- Why Ollie's (OLLI) Shares Are Sliding TodayStockStory11m ago
- Microsoft Held Up as AI Chips Sold Off. Is It the Safer Megacap Bet Now?Motley Fool12m ago
- Mitsubishi Electric to Launch Data-provision Service to Accelerate Adoption of Latest Power SemiconductorsBusiness Wire13m ago
Live discussion
Sign in to join the discussion.
- No comments yet. Be the first.